Antiretroviral therapy in patients with HIV-infections and tuberculosis
Abstract
Modern approaches to using the ART in patients with HIV infection and tuberculosis are presented in article. Prescriptions to start the ART, optimum terms of using the ART and a choice of the most effective and safe scheme of ART, taking into account medicinal interactions
Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus
Abstract
Background. Variation in the IL28B gene is associated with sustained virologic response (SVR) to pegylated interferon plus ribavirin in hepatitis C virus (HCV)–monoinfected patients with genotype 1. Data on other genotypes and on patients coinfected with human
Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons
Abstract
In May 2011, hepatitis C virus (HCV) protease inhibitors (PIs) were approved by the US Food and Drug Administration to treat persons with genotype 1 chronic hepatitis C virus (HCV) infection, but not those dually infected with human immunodeficiency virus (HIV). Although
Results of highly active antiretroviral therapy (start of therapy at 2005–2008 years)
Abstract
The results of highly active antiretroviral therapy application and the reasons of change of its schemes in HIV-infected patients, which have begun therapy in 2005-2008 in the Samara regional center on preventive maintenance and struggle against AIDS and infectious diseases